Huh?  I'm simply making the case of what may have happened to TYTN's pps, the 504 placement dilution aspect aside.  Why are you putting yourself in the spotlight?  I wasn't.  In fact, I wasn't thinking of any poster in particular.  I think it's an example of what we see happen with many OTC offering, especially pinks.  Just my opinions.  Have a good day!